Financial Ratios

DECIPHER LABS LTD.

NSE : NABSE : 524752ISIN CODE : INE643N01012Industry : Pharmaceuticals & DrugsHouse : MNC
BSE6.70-0.7 (-9.46 %)
PREV CLOSE ( ) 7.40
OPEN PRICE ( ) 7.13
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11631
TODAY'S LOW / HIGH ( )6.70 7.13
52 WK LOW / HIGH ( ) 511.95
NSE
This Company is not listed in NSE
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.440.02-2.590.360.10
   CEPS(Rs)-0.420.04-2.530.410.14
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)8.408.848.8211.4111.05
   Tax Rate(%)-0.277.170.81-0.704.18
Margin Ratios
   Core EBITDA Margin(%)-52.170.56-45.4636.631.59
   EBIT Margin(%)-51.450.71-325.7936.2112.12
   Pre Tax Margin(%)-51.450.71-325.7936.2110.29
   PAT Margin (%)-51.590.66-323.1536.469.86
   Cash Profit Margin (%)-49.641.07-316.0641.5314.11
Performance Ratios
   ROA(%)-4.020.21-25.453.130.83
   ROE(%)-5.060.26-25.633.180.87
   ROCE(%)-4.970.28-25.843.141.05
   Asset Turnover(x)0.080.330.080.090.08
   Sales/Fixed Asset(x)3.1814.552.412.704.72
   Working Capital/Sales(x)-2.3325.578.230.390.39
Efficiency Ratios
   Fixed Capital/Sales(x)0.310.070.420.370.21
   Receivable days892.35210.4577.24116.25110.08
   Inventory Days0.000.000.0016.3267.86
   Payable days1067.65429.9999.11
Valuation Parameters
   PER(x)0.00639.390.00148.39351.19
   PCE(x)-25.07394.65-5.60130.28245.35
   Price/Book(x)1.251.671.614.643.03
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)12.664.2217.6254.0634.74
   EV/Core EBITDA(x)-25.59376.04-41.99130.96212.15
   EV/EBIT(x)-24.61593.27-5.41149.29286.57
   EV/CE(x)1.241.671.604.602.97
   M Cap / Sales12.444.2217.6954.1134.62
Growth Ratio
   Net Sales Growth(%)-75.84336.00-18.051.27-31.44
   Core EBITDA Growth(%)-1166.41111.65-183.33155.32-6.55
   EBIT Growth(%)-1849.00100.95-837.33202.54-29.37
   PAT Growth(%)-1989.27100.89-826.28274.64-42.74
   EPS Growth(%)-1986.58100.89-826.28274.64-42.74
Financial Stability Ratios
   Total Debt/Equity(x)0.030.000.000.000.01
   Current Ratio(x)0.471.042.1532.3611.77
   Quick Ratio(x)0.471.042.1531.8111.58
   Interest Cover(x)6.61
   Total Debt/Mcap(x)0.020.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.